Published in Arch Dis Child Fetal Neonatal Ed on October 20, 2005
Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study. BMJ (2010) 2.77
Cognitive/behavioral teratogenetic effects of antiepileptic drugs. Epilepsy Behav (2007) 1.22
Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr Opin Neurol (2009) 0.86
The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism. Int J Mol Sci (2016) 0.81
Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy? Obstet Med (2012) 0.75
Teratogenicity of Antiepileptic Drugs. Clin Psychopharmacol Neurosci (2017) 0.75
Severe consequences of carbamazepine exposure in utero. BMJ Case Rep (2011) 0.75
Long-term consequences after exposure to antiepileptic drugs in utero. Ther Adv Drug Saf (2011) 0.75
Postnatal onset of severe growth retardation after in utero exposure to carbamazepine and phenobarbital: a case report. J Med Case Rep (2009) 0.75
Exposure to Sodium Valproate during Pregnancy: Facial Features and Signs of Autism. Birth Defects Res (2017) 0.75
The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2004) 3.41
Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet (2002) 3.30
Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA (1994) 2.82
Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med (1989) 2.56
Fetal valproate syndrome. J Med Genet (1995) 2.44
The fetal valproate syndrome. Am J Med Genet (1984) 2.04
Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr (1976) 2.00
A case definition and photographic screening tool for the facial phenotype of fetal alcohol syndrome. J Pediatr (1996) 1.88
Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol (1999) 1.73
Verification of the fetal valproate syndrome phenotype. Am J Med Genet (1988) 1.71
The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology (1992) 1.43
Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child (1996) 1.35
Fetal valproate syndrome: is there a recognisable phenotype? J Med Genet (1987) 1.25
Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure (2002) 1.18
The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol (1993) 1.17
Epidemiologic approaches to identifying environmental causes of birth defects. Am J Med Genet C Semin Med Genet (2004) 1.12
Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Am J Med Genet (2001) 1.10
Congenital anomalies in children of epileptic mothers and fathers. Neuropediatrics (1980) 1.09
Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics (1994) 0.99
Developing diagnostic criteria for the fetal anticonvulsant syndromes. Seizure (2000) 0.86
Psychomotor development in children of mothers with epilepsy. Neurology (1992) 0.81
Distal phalangeal hypoplasia in children with prenatal phenytoin exposure: results of a controlled anthropometric study. Am J Med Genet (1990) 0.80
Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet (1997) 6.85
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
The longer term outcome of children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry (2004) 3.41
Epidemiology of tuberous sclerosis. Ann N Y Acad Sci (1991) 2.96
Effects of breastfeeding in children of women taking antiepileptic drugs. Neurology (2010) 2.38
Angelman syndrome: consensus for diagnostic criteria. Angelman Syndrome Foundation. Am J Med Genet (1995) 2.34
Uniparental paternal disomy in Angelman's syndrome. Lancet (1991) 2.26
Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology (2008) 2.24
A procedure for measurement of distribution spaces in isolated fat cells. Biochim Biophys Acta (1972) 2.22
Multilocus linkage identifies two new loci for a mendelian form of stroke, cerebral cavernous malformation, at 7p15-13 and 3q25.2-27. Hum Mol Genet (1998) 2.16
Nail patella syndrome: a review of the phenotype aided by developmental biology. J Med Genet (2003) 1.95
Genetic linkage of cone-rod retinal dystrophy to chromosome 19q and evidence for segregation distortion. Nat Genet (1994) 1.91
Mutations in transcriptional regulator ATRX establish the functional significance of a PHD-like domain. Nat Genet (1997) 1.88
Outcome of low vision aid provision: the effectiveness of a low vision clinic. Optom Vis Sci (1994) 1.80
Exchange of 3-O-methylglucose in isolated fat cells. Concentration dependence and effect of insulin. J Biol Chem (1976) 1.79
Meier-Gorlin syndrome: report of eight additional cases and review. Am J Med Genet (2001) 1.76
A clinical and genetic study of the Say/Barber/Biesecker/Young-Simpson type of Ohdo syndrome. Clin Genet (2008) 1.71
Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet (2001) 1.66
Paternal origin of new mutations in von Recklinghausen neurofibromatosis. Nature (1990) 1.64
Neuropsychological effects of exposure to anticonvulsant medication in utero. Neurology (2005) 1.63
Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway. Hum Mol Genet (1996) 1.57
Assisted reproductive therapies and imprinting disorders--a preliminary British survey. Hum Reprod (2005) 1.48
Biliary atresia in Kabuki syndrome. Am J Med Genet (2000) 1.43
Clinical and hematologic aspects of the X-linked alpha-thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet (1995) 1.42
Effect of endurance training on glucose transport capacity and glucose transporter expression in rat skeletal muscle. Am J Physiol (1990) 1.40
Predictors of clinical hypomagnesemia. Hypokalemia, hypophosphatemia, hyponatremia, and hypocalcemia. Arch Intern Med (1984) 1.40
The cutaneous features of tuberous sclerosis: a population study. Br J Dermatol (1996) 1.40
The role of molecular genetics in the prenatal diagnosis of retinal dystrophies. Eye (Lond) (1995) 1.39
A maternal hypomethylation syndrome presenting as transient neonatal diabetes mellitus. Hum Genet (2006) 1.35
Screening for submicroscopic chromosome rearrangements in children with idiopathic mental retardation using microsatellite markers for the chromosome telomeres. J Med Genet (1999) 1.31
Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function. J Med Genet (2009) 1.31
Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1990) 1.30
Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure (2009) 1.28
Mutational analysis of familial and sporadic hyperekplexia. Ann Neurol (1995) 1.28
Diagnostic criteria, clinical characteristics, and natural history of Cohen syndrome. J Med Genet (2003) 1.26
Phenotypic variability and asymmetry of Rieger syndrome associated with PITX2 mutations. Invest Ophthalmol Vis Sci (2000) 1.26
New domains of neural cell-adhesion molecule L1 implicated in X-linked hydrocephalus and MASA syndrome. Am J Hum Genet (1995) 1.25
Somatic mutation in MECP2 as a non-fatal neurodevelopmental disorder in males. Lancet (2000) 1.24
Coats' disease of the retina (unilateral retinal telangiectasis) caused by somatic mutation in the NDP gene: a role for norrin in retinal angiogenesis. Hum Mol Genet (1999) 1.22
Aarskog-Scott syndrome: clinical update and report of nine novel mutations of the FGD1 gene. Am J Med Genet A (2010) 1.21
Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet (2005) 1.18
The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene. J Med Genet (2005) 1.15
Effects of fetal antiepileptic drug exposure: outcomes at age 4.5 years. Neurology (2012) 1.15
Time course of insulin-receptor binding and insulin-induced lipogenesis in isolated rat fat cells. J Biol Chem (1975) 1.15
Genetic heterogeneity in tuberous sclerosis. Study of a large collaborative dataset. Ann N Y Acad Sci (1991) 1.14
GLUT 4 and insulin receptor binding and kinase activity in trained human muscle. J Physiol (1993) 1.14
Kinetics of glucose transport in rat muscle: effects of insulin and contractions. Am J Physiol (1987) 1.11
Further delineation of Pitt-Hopkins syndrome: phenotypic and genotypic description of 16 novel patients. J Med Genet (2008) 1.10
Common antiepileptic drugs in pregnancy in women with epilepsy. Cochrane Database Syst Rev (2004) 1.09
The human glutathione S-transferases. Immunohistochemical studies of the developmental expression of Alpha- and Pi-class isoenzymes in liver. Biochem J (1988) 1.07
A 90 kb DNA deletion associated with neurofibromatosis type 1. J Med Genet (1990) 1.07
Evolving phenotype of Marfan's syndrome. Arch Dis Child (1997) 1.06
Cerebral screening in patients with hereditary haemorrhagic telangiectasia. Intern Med J (2014) 1.06
The ophthalmic findings in Cohen syndrome. Br J Ophthalmol (2002) 1.04
Close flanking markers for neurofibromatosis type I (NF1). Am J Hum Genet (1989) 1.03
Ohdo-like blepharophimosis syndrome with distinctive facies, neonatal hypotonia, mental retardation and hypoplastic teeth. Clin Dysmorphol (1994) 1.03
The non-deletion alpha thalassaemia/mental retardation syndrome: further support for X linkage. J Med Genet (1991) 1.00
cav-p60 expression in rat muscle tissues. Distribution of caveolar proteins. Cell Tissue Res (2001) 1.00
Increased activities of mitochondrial enzymes in white adipose tissue in trained rats. Am J Physiol (1991) 0.99
Epimutation of the TNDM locus and the Beckwith-Wiedemann syndrome centromeric locus in individuals with transient neonatal diabetes mellitus. Hum Genet (2006) 0.99
The behavioral consequences of exposure to antiepileptic drugs in utero. Epilepsy Behav (2008) 0.99
Magnesium and potassium interrelationships, experimental and clinical. Acta Med Scand Suppl (1981) 0.99
Recurrent Wiedemann-Beckwith syndrome with inversion of chromosome (11)(p11.2p15.5). Am J Med Genet (1992) 0.98
Tylosis associated with carcinoma of the oesophagus and oral leukoplakia in a large Liverpool family--a review of six generations. Eur J Cancer B Oral Oncol (1994) 0.98
A survey of TWIST for mutations in craniosynostosis reveals a variable length polyglycine tract in asymptomatic individuals. Hum Mutat (2001) 0.97
Large scale deletions in the GPC3 gene may account for a minority of cases of Simpson-Golabi-Behmel syndrome. J Med Genet (1997) 0.97
Jointly amplified basal and pulsatile growth hormone (GH) secretion and increased process irregularity in women with anorexia nervosa: indirect evidence for disruption of feedback regulation within the GH-insulin-like growth factor I axis. J Clin Endocrinol Metab (1999) 0.97
Deletions in the VPS13B (COH1) gene as a cause of Cohen syndrome. Hum Mutat (2009) 0.96
FISH mapping of de novo apparently balanced chromosome rearrangements identifies characteristics associated with phenotypic abnormality. Am J Hum Genet (2008) 0.96
Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects. Diabetologia (1996) 0.96
Effect of physical training on glucose transporter protein and mRNA levels in rat adipocytes. Am J Physiol (1993) 0.94
Caveolae, caveolin and cav-p60 in smooth muscle and renin-producing cells in the rat kidney. Acta Physiol Scand (2003) 0.92
A rapid technique for separation of thymocytes from suspensions by centrifugation through silicone oil. Anal Biochem (1974) 0.92
Comparison of genetic services with and without genetic registers: access and attitudes to genetic counselling services among relatives of genetic clinic patients. J Med Genet (2002) 0.92
SALL4 deletions are a common cause of Okihiro and acro-renal-ocular syndromes and confirm haploinsufficiency as the pathogenic mechanism. J Med Genet (2004) 0.92
Susceptibility to multiple cutaneous basal cell carcinomas: significant interactions between glutathione S-transferase GSTM1 genotypes, skin type and male gender. Br J Cancer (1996) 0.91
Kinetics of glucose transport in rat skeletal muscle membrane vesicles: effects of insulin and contractions. Am J Physiol (1992) 0.90
Vaginal rhabdomyosarcoma in a patient with Noonan syndrome. J Med Genet (1995) 0.90
Effect of training on epinephrine-stimulated lipolysis determined by microdialysis in human adipose tissue. Am J Physiol (1995) 0.90
Angelman syndrome associated with a maternal 15q11-13 deletion of less than 200 kb. Hum Mol Genet (1994) 0.90
Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats. Diabetologia (1993) 0.90
Tall stature and duplication of the insulin-like growth factor I receptor gene. Eur J Med Genet (2006) 0.89
Folate and clefts of the lip and palate--a U.K.-based case-control study: Part I: Dietary and supplemental folate. Cleft Palate Craniofac J (2008) 0.88
Cytochalasin B inhibition and temperature dependence of 3-O-methylglucose transport in fat cells. Biochim Biophys Acta (1978) 0.88
Insulin receptors in fat cells: relationship between binding and activation. Isr J Med Sci (1975) 0.88
Folate and clefts of the lip and palate--a U.K.-based case-control study: Part II: Biochemical and genetic analysis. Cleft Palate Craniofac J (2007) 0.87
Quantitation of Na+/K(+)-ATPase and glucose transporter isoforms in rat adipocyte plasma membrane by immunogold labeling. J Membr Biol (1993) 0.87
Systematic screening of FBN1 gene unclassified missense variants for splice abnormalities. Clin Genet (2011) 0.87
MRI and neurological findings in macrocephaly-cutis marmorata telangiectatica congenita syndrome: report of ten cases and review of the literature. Genet Couns (2005) 0.87
Cerebellar ataxia, areflexia, pes cavus, optic atrophy, and sensorineural hearing loss (CAPOS): a new syndrome. J Med Genet (1996) 0.87
Monozygotic twins with 22q11 deletion and discordant phenotypes. J Med Genet (1996) 0.86
Familial patent ductus arteriosus: a further case of CHAR syndrome. Am J Med Genet (1997) 0.86
Membrane specific carbonic anhydrase (CAIV) expression in human tissues. Biochim Biophys Acta (1990) 0.86
Array comparative genomic hybridization for diagnosis of developmental delay: an exploratory cost-consequences analysis. Clin Genet (2007) 0.86
Glutathione S-transferase and cytochrome-P-450 polymorphism as risk factors for squamous cell carcinoma of the larynx. Am J Surg (1996) 0.86